Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility

This publication has 11 references indexed in Scilit:

• Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation
  Human Reproduction, 1994
• Induction of pre-ovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome
  Human Reproduction, 1994
• Evolving role of gonadotropin-releasing hormone antagonists
  Trends in Endocrinology & Metabolism, 1992
• The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: Experience from three centres
  Human Reproduction, 1992
• The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women
  American Journal of Obstetrics and Gynecology, 1991
• An 18-month survey of infertility treatment by in vitro fertilization, gamete and zygote intrafallopian transfer, and replacement of frozen-thawed embryos
  Journal of Assisted Reproduction and Genetics, 1989
• The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT
  Human Reproduction, 1988
• Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis
  Fertility and Sterility, 1984
• Receptor-Binding Affinity of Gonadotropin-Releasing Hormone Analogs: Analysis by Radioligand-Receptor Assay
  Endocrinology, 1980
• Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence
  Biochemical and Biophysical Research Communications, 1971